MAPK pathway, of which aberrations are linked to many types of cancers, was identified as a key regulator of the final nephron number in a mature kidney.

TOP INSIGHT
MAPK activity modulators give hope for the development of stem cell-based regenerative therapies as novel treatments for patients suffering from renal diseases.
Development of new diagnostic and therapeutic modalities for renal diseases requires detailed knowledge of the mechanisms regulating kidney development.
MAPK pathway mediates extracellular growth factor stimuli to the cell interior. It has functions in both the cell nucleus, where it controls DNA by binding to target regions, and in the cytosol, where it regulates activities of many different proteins.
- Our results reveal that MAPK activity participates in modulating cellular adhesion, which is constantly required in developing systems to enable cellular motility and morphogenesis, explains the principal investigator Satu Kuure from the University of Helsinki, Finland.
- Use of MAPK modulators allows efficient and precise activation as well as inactivation of the pathway. Timely utilization of this in patient-derived organoid differentiation may significantly improve the outcome, foresees Kuure.
MEDINDIA




Email










